China National Medicines

China National Medicines is one of the...

• CSI 500.

China National Medicines is a company listed under the stock ticker 600511 (CN).

View the org chart displaying its 13 main executives

Most searched biographies at China National Medicines

• Kuoh Yang Lim, Executive Director and Chief Executive Officer
• Chee Kong Choo, Executive Vice Chairman and Executive Director
• Xiang Xiong, Executive Chairman and Executive Director

Create your alert
to follow the executive moves at China National Medicines.

China National Medicines has 1,865 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by China National Medicines

Social media about China National Medicines

• China National Medicines on Wikipedia, Google News & Yahoo Finance
• China National Medicines on LinkedIn, Twitter & YouTube

Contact by email its executives including Cheng Tuck Kuan

Call China National Medicines at +86 106...

View the org chart

Register to receive your alert

Report an error